BioSpace News Archive

Drug Development

Kythera Biopharmaceuticals Announces Presentation of Positive Results from First of Two ATX-101 European Phase III Trials for Reduction of Submental Fat

May 7, 2012
·
6 min read
Business

Maria Sainz Joins CardioKinetix Inc. as President and Chief Executive Officer

May 7, 2012
·
2 min read
Biotech Bay

Kerberos to Sell FDA Cleared Rinspiration Technology

May 7, 2012
·
2 min read
Business

Advanced Cardiac Therapeutics Announces Several Key Appointments

May 7, 2012
·
5 min read
Nuvo Research Inc.'s Pliaglis Receives Positive Opinion from the BfArM in the E.U.

May 7, 2012
·
5 min read
Drug Development

Dainippon Sumitomo Pharma Co., Ltd. Reports that Latuda® (lurasidone HCl) Met Primary and Key Secondary Endpoints in Two Phase III Trials in Bipolar I Depression

May 7, 2012
·
16 min read
Drug Development

PROLOR Biotech Announces Top-Line Results from Four-Month Treatment Extension of its Long-Acting Human Growth Hormone Phase II Trial

May 7, 2012
·
6 min read
Drug Development

Galleon Pharmaceuticals, Inc. Reports Positive Results from Phase I Study of GAL-021 for Treatment of Respiratory Depression

May 7, 2012
·
2 min read
Policy

Bayer AG Challenges Nexavar Generic Licence Order

May 7, 2012
·
1 min read
Drug Development

New Phase III Data Show Agile Therapeutics, Inc.’' Low-Dose Patch is Comparable to Combination Oral Contraceptive in a Comparator Study

May 7, 2012
·
3 min read